Royal Philips has launched the EXIT-CVD research consortium, a five-year initiative aimed at transforming cardiovascular care across Europe. The project is co-funded by the European Union’s Innovative Health Initiative (IHI) and various industry partners.
The program focuses on improving the detection and management of cardiovascular diseases. By leveraging collaborative research, the consortium seeks to enhance clinical outcomes and streamline patient care pathways throughout the region.
In-depth summary · AI, neutral